Rein Therapeutics Inc (NASDAQ: RNTX) established initial surge of 8.41% at $1.16, as the Stock market unbolted on Wednesday, before settling in for the price of $1.07 at the close. Taking a more long-term approach, RNTX posted a 52-week range of $1.02-$3.50.
The Healthcare sector firm’s twelve-monthly sales growth has been 31.90% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was 31.90%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 72.79%. This publicly-traded company’s shares outstanding now amounts to $25.14 million, simultaneously with a float of $24.55 million. The organization now has a market capitalization sitting at $30.50 million. At the time of writing, stock’s 50-day Moving Average stood at $1.4047, while the 200-day Moving Average is $1.4972.
Rein Therapeutics Inc (RNTX) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Rein Therapeutics Inc industry. Rein Therapeutics Inc’s current insider ownership accounts for 6.61%, in contrast to 27.34% institutional ownership. According to the most recent insider trade that took place on Nov 14 ’25, this organization’s 10% Owner bought 104,183 shares at the rate of 1.22, making the entire transaction reach 127,593 in total value, affecting insider ownership by 926,441. Preceding that transaction, on Oct 28 ’25, Company’s 10% Owner bought 178,392 for 1.39, making the whole transaction’s value amount to 247,965. This particular insider is now the holder of 500,000 in total.
Rein Therapeutics Inc (RNTX) Earnings and Revenue Records
Rein Therapeutics Inc’s EPS increase for this current 12-month fiscal period is 72.79% and is forecasted to reach -0.80 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 36.00% through the next 5 years, which can be compared against the 31.90% growth it accomplished over the previous five years trading on the market.
Rein Therapeutics Inc (NASDAQ: RNTX) Trading Performance Indicators
Let’s observe the current performance indicators for Rein Therapeutics Inc (RNTX). It’s Quick Ratio in the last reported quarter now stands at 0.90.
In the same vein, RNTX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.64, a figure that is expected to reach -0.21 in the next quarter, and analysts are predicting that it will be -0.80 at the market close of one year from today.
Technical Analysis of Rein Therapeutics Inc (RNTX)
Now, what If we examine the latest scores posted by [Rein Therapeutics Inc, RNTX]. During the last 5-days, its volume was better the volume of 0.3 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 15.00% While, its Average True Range was 36.08.
Raw Stochastic average of Rein Therapeutics Inc (RNTX) in the period of the previous 100 days is set at 12.07%, which indicates a major fall in contrast to 25.93% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.1160 that was lower than 0.1263 volatility it exhibited in the past 100-days period.
